Efficacy of Elbasvir/Grazoprevir Therapy in HCV Genotype-1 with or without HIV Infection: Role of HCV Core Antigen Monitoring and Improvement of Liver Stiffness and Steatosis
Maneerat Chayanupatkul(Chulalongkorn University), Pisit Tangkijvanich(Chulalongkorn University), Pornpitra Pratedrat(Chulalongkorn University), Anchalee Avihingsanon(Chulalongkorn University), S. Chittmittraprap(Chulalongkorn University), Natthaya Chuaypen(Chulalongkorn University)
Cited by 6
Related Papers
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
|Gastroenterology|2017|929
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
|Gastroenterology|2018|796
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons
|New England Journal of Medicine|2024|260
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection
|Journal of Hepatology|2016|139
Cirrhotic cardiomyopathy: review of pathophysiology and treatment
|Hepatology International|2014|118